Kamdar, Anna
Morrow, Andrew J.
Sykes, Robert
McIntosh, Alasdair
Bagot, Catherine
Bayes, Hannah K.
Blyth, Kevin G.
Church, Colin
Gillespie, Lynsey
Roditi, Giles
Stobo, David
Weeden, Sarah
Welsh, Paul
Mangion, Kenneth
McConnachie, Alex
Berry, Colin
,
Article History
Received: 11 June 2025
Accepted: 26 December 2025
First Online: 20 January 2026
Declarations
:
: The CISCO-19 study was approved by the UK National Research Ethics Service reference number; 20/NS/0066. All participants provided written informed consent prior to enrolment. All methodology were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki).
: Not applicable.
: Colin Berry is employed by the University of Glasgow which holds consultancy and research agreements for his work with Abbott Vascular, AskBio, AstraZeneca, Boehringer Ingelheim, CorFlow, Edwards Lifesciences, Merck, Servier, Novartis, Roche, Siemens Healthcare, and Zoll Medical. Colin Berry receives research funding from the British Heart Foundation (RG/F/23/110104, FS/MBPhD/22/28011, PG/19/28/34310, PG/18/52/33892) and Medical Research Council (MR/S018905/1).